Functional and clinical significance of variants localized to 8q24 in colon cancer.
Multiple genome-wide association studies have identified several susceptibility variants for colon cancer at 8q24. However, the functional roles of these variants have yet to be elucidated. Here, we evaluated the potential role of these markers in tumor progression and examined association with commonly observed structural abnormalities in this region, c-MYC amplification and chromosome fragility at FRA8C and FRA8D. We first replicated the previously reported association by testing 1,178 cases and 1,009 clinic-based controls with eight markers localized to three specific regions at 8q24. We observed significant associations with colon cancer risk with markers rs13254738 (ordinal odds ratio, 0.82; 95% confidence interval, 0.072-0.94; P(trend) = 0.0037) and rs6983267 (ordinal odds ratio, 1.17; 95% confidence interval, 1.03-1.32, P(trend) = 0.013). Survival analysis was done using a separate set of 460 cases to evaluate the clinical significance of these markers. Overall, univariate analysis did not detect survival differences for any of the markers. We also tested a subset of the 460 cases (n = 380) for structural abnormalities at or near the c-MYC locus using fluorescence in situ hybridization analysis. Furthermore, we evaluated a small number of cases homozygous for the rs6983267 alleles to test for differences in fragile site induction. None of the 8q markers correlated with amplification at the c-MYC locus as detected by fluorescence in situ hybridization, and no clear pattern of breakage was observed at the FRA8C and FRA8D sites. In this study, we confirm the association for several single nucleotide polymorphisms at 8q24 in colon cancer but have not detected any structural role relating to c-MYC amplification or chromosomal fragility. Finally, these risk alleles do not seem to be associated with survival.
Cicek
Mine S
MS
Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street Southwest, 920 Hilton Building, Rochester, MN 55905, USA.
Slager
Susan L
SL
Achenbach
Sara J
SJ
French
Amy J
AJ
Blair
Hilary E
HE
Fink
Stephanie R
SR
Foster
Nathan R
NR
Kabat
Brian F
BF
Halling
Kevin C
KC
Cunningham
Julie M
JM
Cerhan
James R
JR
Jenkins
Robert B
RB
Boardman
Lisa A
LA
Petersen
Gloria M
GM
Sargent
Daniel J
DJ
Alberts
Steven R
SR
Limburg
Paul J
PJ
Thibodeau
Stephen N
SN
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016022:Case-Control Studies; D002898:Chromosomes, Human, Pair 8; D003110:Colonic Neoplasms / Q000235:genetics* / Q000473:pathology; D053843:DNA Mismatch Repair; D005260:Female; D020022:Genetic Predisposition to Disease; D014644:Genetic Variation; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D008297:Male; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide; D011446:Prospective Studies; D012307:Risk Factors; D015996:Survival Rate; D055815:Young Adult
Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1295-302
19318433
Cancer Res. 2007 Apr 1;67(7):2951-6
17409400
Nat Genet. 2007 Aug;39(8):984-8
17618284
Oncogene. 2003 Oct 16;22(46):7233-42
14562053
J Clin Oncol. 2002 Feb 15;20(4):1043-8
11844828
Hum Genet. 1984;67(2):136-42
6430783
Nat Genet. 2007 Aug;39(8):954-6
17618282
Cancer Res. 1998 Nov 15;58(22):5248-57
9823339
Anticancer Res. 2006 Sep-Oct;26(5A):3439-44
17094464
Clin Colorectal Cancer. 2006 Jul;6(2):133-9
16945169
Nat Genet. 2007 Aug;39(8):989-94
17618283
Cancer Biol Ther. 2007 Jul;6(7):1143-7
17630503
Hum Mol Genet. 2008 Sep 1;17(17):2665-72
18535017
Nat Genet. 2007 May;39(5):638-44
17401364
Cancer Res. 2008 Jan 1;68(1):14-7
18172290
Genes Chromosomes Cancer. 2005 Dec;44(4):438-49
16130124
Nat Genet. 2007 May;39(5):631-7
17401366
Nat Genet. 2007 May;39(5):645-9
17401363
Am J Hum Genet. 2001 Oct;69(4):780-90
11524701
Nature. 2007 Jun 28;447(7148):1087-93
17529967
Hum Genet. 2008 Sep;124(2):161-70
18704501
Nat Genet. 2008 May;40(5):623-30
18372905
Nat Genet. 2008 May;40(5):631-7
18372901
Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14068-73
16945910
Genes Chromosomes Cancer. 1996 Apr;15(4):234-45
8703849
Cancer Res. 2007 Dec 1;67(23):11128-32
18056436
Cancer Res. 2004 Jul 15;64(14):4817-25
15256451
Nat Genet. 2006 Jun;38(6):652-8
16682969
Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):339-42
18268117
J Natl Cancer Inst. 2008 Jul 2;100(13):962-6
18577746
Cancer Res. 1998 Apr 15;58(8):1713-8
9563488